Target intelligence / Profile preview

microRNA-33b (miR-33b)

Target
miR-33b
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

microRNA-33b (miR-33b) is a primate-specific microRNA located within the intronic region of the sterol regulatory element-binding protein 1 (SREBF1) gene. It serves as a master regulator of lipid and glucose metabolism by post-transcriptionally silencing genes involved in cholesterol efflux (such as ABCA1) and fatty acid oxidation (such as CPT1A). Dysregulation of miR-33b is strongly associated with metabolic and cardiovascular diseases, including atherosclerosis, dyslipidemia, and non-alcoholic fatty liver disease. In addition to its metabolic roles, miR-33b acts as a tumor suppressor in various cancers by inhibiting cell proliferation and migration. Therapeutic strategies targeting miR-33b, primarily using antisense oligonucleotides, are being investigated to improve lipid profiles and treat metabolic disorders, although systemic inhibition requires careful management to avoid side effects like obesity.

Other names
MIR33Bhsa-miR-33bmicroRNA 33b-5pmicroRNA 33b-3p
02

Mechanism of action

Post-transcriptional regulation of gene expression by binding to the 3-untranslated regions (3-UTRs) of target messenger RNAs (mRNAs), leading to translational repression or mRNA degradation.

03

Biological functions

Cholesterol homeostasisFatty acid metabolismInsulin signalingInflammatory regulationGlucose metabolismHepatic gluconeogenesisCell proliferationApoptosis
04

Disease associations

Cardiovascular diseaseMetabolic diseaseDyslipidemiaAtherosclerosisMetabolic dysfunction-associated steatotic liver disease (MASLD)Non-alcoholic fatty liver disease (NAFLD)ObesityDiabetesCancer
05

Safety considerations

Systemic inhibition may lead to obesity due to roles in hunger signalingPotential for off-target effects in the central nervous systemTissue-specific delivery challenges to avoid metabolic side effects
06

Interacting drugs

Atorvastatin

5 more in the full profile.

07

Biomarkers

Circulating miR-33b levelsPlasma miR-33b-5p

Beyond the preview

Go deeper on microRNA-33b (miR-33b).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA-33b (miR-33b).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call